Bellevue Group AG
- SEC CIK
- 0001674546
- Latest filing
- Aug 14, 2026
Holdings in Q1 2023
Holdings as of Mar 31, 2023, filed May 15, 2023. Long positions only; changes compare share counts with Q4 2022.
- Positions
- 159
- −12 vs. Q4 2022
- Portfolio value
- $6.89B
- −$643.5M (−8.5%) vs. Q4 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ZBHZimmer Biomet Holdings, Inc. | Stock | 265,270 | $34.3M | 0.5% | −1,026−0.4% | Reduced | History |
| IQVIQVIA Holdings Inc. | Stock | 172,478 | $34.3M | 0.5% | −10,842−5.9% | Reduced | History |
| CNCCentene Corp | Stock | 549,341 | $34.7M | 0.5% | −144,217−20.8% | Reduced | History |
| GMEDGlobus Medical Inc | Stock | 647,645 | $36.7M | 0.5% | −32,535−4.8% | Reduced | History |
| MOHMolina Healthcare, Inc. | COM | 142,609 | $38.1M | 0.6% | −43,405−23.3% | Reduced | History |
| AMEDAmedisys Inc | COM | 542,616 | $39.9M | 0.6% | −70,896−11.6% | Reduced | History |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | 899,800 | $40.7M | 0.6% | −11,905−1.3% | Reduced | History |
| SILKSilk Road Medical Inc | COM | 1,069,739 | $41.9M | 0.6% | +57,216+5.7% | Added | History |
| ELVElevance Health, Inc. | Stock | 92,970 | $42.7M | 0.6% | −56,451−37.8% | Reduced | History |
| TMDXTransMedics Group, Inc. | COM | 629,484 | $47.7M | 0.7% | −52,574−7.7% | Reduced | History |
| VEEVVeeva Systems Inc | Stock | 262,985 | $48.3M | 0.7% | +76,728+41.2% | Added | History |
| TMOThermo Fisher Scientific Inc. | Stock | 86,333 | $49.8M | 0.7% | +3,004+3.6% | Added | History |
| EXELExelixis, Inc. | COM | 2,609,000 | $50.6M | 0.7% | −64,500−2.4% | Reduced | History |
| OMOutset Medical, Inc. | COM | 2,906,759 | $53.5M | 0.8% | +63,080+2.2% | Added | History |
| BIOBio-Rad Laboratories, Inc. | CL A | 113,739 | $54.5M | 0.8% | +2,581+2.3% | Added | History |
| IDXXIDEXX Laboratories Inc | COM | 110,928 | $55.5M | 0.8% | +2,106+1.9% | Added | History |
| INSMINSMED Inc | COM PAR $.01 | 3,293,102 | $56.1M | 0.8% | +15,895+0.5% | Added | History |
| ALGNAlign Technology Inc | COM | 171,140 | $57.2M | 0.8% | +91,946+116.1% | Added | History |
| ARVNArvinas, Inc. | COM | 2,127,000 | $58.1M | 0.8% | −23,412−1.1% | Reduced | History |
| ACCDAccolade, Inc. | COM | 4,041,801 | $58.1M | 0.8% | +364,524+9.9% | Added | History |
| SWAVShockwave Medical, Inc. | COM | 281,376 | $61.0M | 0.9% | +33,760+13.6% | Added | History |
| CRLCharles River Laboratories International, Inc. | COM | 302,446 | $61.0M | 0.9% | +12,469+4.3% | Added | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 1,800,000 | $64.8M | 0.9% | 00.0% | Unchanged | History |
| PENPenumbra Inc | COM | 238,172 | $66.4M | 1.0% | +12,355+5.5% | Added | History |
| RLAYRelay Therapeutics, Inc. | COM | 4,172,600 | $68.7M | 1.0% | −32,220−0.8% | Reduced | History |
| MGNXMacrogenics Inc | COM | 9,609,913 | $68.9M | 1.0% | +630,000+7.0% | Added | History |
| EVHEvolent Health, Inc. | CL A | 2,191,147 | $71.1M | 1.0% | +207,494+10.5% | Added | History |
| TNDMTandem Diabetes Care Inc | COM NEW | 1,793,763 | $72.8M | 1.1% | +2,313+0.1% | Added | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 1,109,382 | $73.2M | 1.1% | +5,165+0.5% | Added | History |
| OPCHOption Care Health, Inc. | COM NEW | 2,442,185 | $77.6M | 1.1% | +11,763+0.5% | Added | History |
| HCAHCA Healthcare, Inc. | COM | 303,786 | $80.1M | 1.2% | −27,520−8.3% | Reduced | History |
| PACBPacific Biosciences of California, Inc. | COM | 7,026,106 | $81.4M | 1.2% | +547,181+8.4% | Added | History |
| EXASExact Sciences Corp | COM | 1,225,042 | $83.1M | 1.2% | −86,973−6.6% | Reduced | History |
| JAZZJazz Pharmaceuticals plc | SHS USD | 569,857 | $83.4M | 1.2% | −186,779−24.7% | Reduced | History |
| DHRDanaher Corp | Stock | 337,391 | $85.0M | 1.2% | −28,959−7.9% | Reduced | History |
| EWEdwards Lifesciences Corp | Stock | 1,040,669 | $86.1M | 1.2% | −23,462−2.2% | Reduced | History |
| BDXBecton Dickinson & Co | Stock | 348,043 | $86.2M | 1.3% | +16,483+5.0% | Added | History |
| DXCMDexcom Inc | COM | 755,079 | $87.7M | 1.3% | −233,397−23.6% | Reduced | History |
| INSPInspire Medical Systems, Inc. | COM | 377,068 | $88.3M | 1.3% | −24,674−6.1% | Reduced | History |
| SRPTSarepta Therapeutics, Inc. | COM | 646,614 | $89.1M | 1.3% | −46,595−6.7% | Reduced | History |
| UNHUnitedHealth Group Inc | Stock | 194,811 | $92.1M | 1.3% | −29,483−13.1% | Reduced | History |
| AGIOAgios Pharmaceuticals, Inc. | COM | 4,013,500 | $92.2M | 1.3% | −43,292−1.1% | Reduced | History |
| MDTMedtronic plc | Stock | 1,229,235 | $99.1M | 1.4% | +610,815+98.8% | Added | History |
| RVMDRevolution Medicines, Inc. | COM | 4,747,900 | $102.8M | 1.5% | −107,262−2.2% | Reduced | History |
| PODDInsulet Corp | Stock | 323,594 | $103.2M | 1.5% | −22,186−6.4% | Reduced | History |
| AXNXAxonics, Inc. | COM | 1,911,861 | $104.3M | 1.5% | +5,400+0.3% | Added | History |
| SAGESage Therapeutics, Inc. | COM | 3,090,000 | $129.7M | 1.9% | +120,722+4.1% | Added | History |
| SYKStryker Corp | Stock | 484,774 | $138.4M | 2.0% | −7,460−1.5% | Reduced | History |
| ABTAbbott Laboratories | Stock | 1,646,916 | $166.8M | 2.4% | −37,563−2.2% | Reduced | History |
| BSXBoston Scientific Corp | Stock | 3,439,579 | $172.1M | 2.5% | −463,345−11.9% | Reduced | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 883,250 | $176.9M | 2.6% | −37,963−4.1% | Reduced | History |
| ITCIIntra-Cellular Therapies, Inc. | COM | 3,268,000 | $177.0M | 2.6% | −74,236−2.2% | Reduced | History |
| INCYIncyte Corp | COM | 2,840,500 | $205.3M | 3.0% | −116,477−3.9% | Reduced | History |
| MRNAModerna, Inc. | Stock | 1,551,706 | $238.3M | 3.5% | −30,622−1.9% | Reduced | History |
| ISRGIntuitive Surgical Inc | COM NEW | 968,786 | $247.5M | 3.6% | +11,700+1.2% | Added | History |
| NBIXNeurocrine Biosciences Inc | Stock | 2,613,300 | $264.5M | 3.8% | −159,994−5.8% | Reduced | History |
| ARGXArgenx SE | SPONSORED ADR | 886,928 | $330.5M | 4.8% | −24,172−2.7% | Reduced | History |
| IONSIonis Pharmaceuticals Inc | COM | 9,511,900 | $340.0M | 4.9% | −232,000−2.4% | Reduced | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 1,145,695 | $361.0M | 5.2% | +49,667+4.5% | Added | History |
Sold out since Q4 2022 (19)
Positions held at the end of Q4 2022 that are gone from this filing.
| Security | Class | Shares in Q4 2022 | Value in Q4 2022 | % of portfolio in Q4 2022 | History |
|---|---|---|---|---|---|
| MYOVMyovant Sciences Ltd. | COM | 5,910,639 | $159.4M | 2.1% | History |
| ADPTAdaptive Biotechnologies Corp | COM | 2,960,131 | $22.6M | 0.3% | History |
| AVTRAvantor, Inc. | COM | 471,621 | $9.95M | 0.1% | History |
| TFXTeleflex Inc | COM | 25,066 | $6.26M | 0.1% | History |
| AUPHAurinia Pharmaceuticals Inc. | COM | 1,290,278 | $5.57M | 0.1% | History |
| QTTBQ32 Bio Inc. | COM | 1,622,522 | $2.04M | <0.1% | History |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 12,411 | $1.41M | <0.1% | History |
| RCUSArcus Biosciences, Inc. | COM | 65,864 | $1.36M | <0.1% | History |
| AAgilent Technologies, Inc. | COM | 7,978 | $1.19M | <0.1% | History |
| CELLBruker Cellular Analysis, Inc. | COM | 385,014 | $1.03M | <0.1% | History |
| NVCRNovoCure Ltd | ORD SHS | 9,000 | $660.0K | <0.1% | History |
| Bellus Health Inc New07987C204 | COM NEW | 44,905 | $369.1K | <0.1% | – |
| DSGNDesign Therapeutics, Inc. | COM | 34,881 | $357.9K | <0.1% | History |
| MKTXMarketaxess Holdings Inc | COM | 662 | $184.6K | <0.1% | History |
| MELIMercadolibre Inc | COM | 170 | $143.9K | <0.1% | History |
| DLBDolby Laboratories, Inc. | COM CL A | 1,600 | $112.9K | <0.1% | History |
| ACHCAcadia Healthcare Company, Inc. | COM | 1,287 | $105.9K | <0.1% | History |
| UTHRUnited Therapeutics Corp | COM | 212 | $59.0K | <0.1% | History |
| NKTRNektar Therapeutics | COM | 14,800 | $33.4K | <0.1% | History |